Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(IO-102 + IO-103) by IO Biotech for Oral Cavity (Mouth) Cancer: Likelihood of Approval
(IO-102 + IO-103) is under clinical development by IO Biotech and currently in Phase II for Oral Cavity (Mouth) Cancer....
(IO-102 + IO-103) by IO Biotech for Oropharyngeal Cancer: Likelihood of Approval
(IO-102 + IO-103) is under clinical development by IO Biotech and currently in Phase II for Oropharyngeal Cancer. According to...
(IO-102 + IO-103) by IO Biotech for Laryngeal Cancer: Likelihood of Approval
(IO-102 + IO-103) is under clinical development by IO Biotech and currently in Phase II for Laryngeal Cancer. According to...
(IO-102 + IO-103) by IO Biotech for Hypopharyngeal Cancer: Likelihood of Approval
(IO-102 + IO-103) is under clinical development by IO Biotech and currently in Phase II for Hypopharyngeal Cancer. According to...
(IO-102 + IO-103) by IO Biotech for Melanoma: Likelihood of Approval
(IO-102 + IO-103) is under clinical development by IO Biotech and currently in Phase II for Melanoma. According to GlobalData,...